Atlas Trials

Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease

Clinical trial NCT05121142 · COMPLETED

Trial details

NCT number
NCT05121142
Sponsor
Children's Hospital Medical Center, Cincinnati
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute-graft-versus-host DiseaseChronic Graft-versus-host-diseaseSolid Organ Transplant
Start date
2021-10-27
Primary completion
2023-05-13
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.